Should variants of unknown significance (VUS) be disclosed to patients in cardiogenetics or not; only in case of high suspicion of pathogenicity?
作者信息
van der Crabben Saskia N, Mörner Stellan, Lundström Anna C, Jonasson Jenni, Bikker Hennie, Amin Ahmad S, Rydberg Annika, Wilde Arthur A M
机构信息
Department of Clinical Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
European Reference Network for rare, low-prevalence, or complex diseases of the heart (ERN GUARD-Heart), Amsterdam, the Netherlands.
出版信息
Eur J Hum Genet. 2022 Nov;30(11):1208-1210. doi: 10.1038/s41431-022-01173-z. Epub 2022 Aug 26.
Abstract
摘要
相似文献
1
Should variants of unknown significance (VUS) be disclosed to patients in cardiogenetics or not; only in case of high suspicion of pathogenicity?
Eur J Hum Genet. 2022 Nov;30(11):1208-1210. doi: 10.1038/s41431-022-01173-z. Epub 2022 Aug 26.
2
Factors predicting reclassification of variants of unknown significance.
Am J Surg. 2018 Dec;216(6):1148-1154. doi: 10.1016/j.amjsurg.2018.08.008. Epub 2018 Sep 7.
3
Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
Ann Surg Oncol. 2019 Oct;26(10):3389-3396. doi: 10.1245/s10434-019-07595-2. Epub 2019 Jul 24.
4
Functional Categorization of Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation Assays.
Clin Cancer Res. 2020 Sep 1;26(17):4559-4568. doi: 10.1158/1078-0432.CCR-20-0255. Epub 2020 Jun 16.
5
Understanding variants of uncertain significance in the era of multigene panels: Through the eyes of the patient.
J Genet Couns. 2019 Aug;28(4):878-886. doi: 10.1002/jgc4.1130. Epub 2019 May 3.
6
Preconception carrier screening yield: effect of variants of unknown significance in partners of carriers with clinically significant variants.
Genet Med. 2020 Mar;22(3):646-653. doi: 10.1038/s41436-019-0676-x. Epub 2019 Oct 17.
7
A likelihood-based approach to assessing frequency of pathogenicity among variants of unknown significance in susceptibility genes.
Stat Med. 2021 Feb 10;40(3):593-606. doi: 10.1002/sim.8791. Epub 2020 Oct 29.
8
How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?
BMC Med Genomics. 2022 May 31;15(1):122. doi: 10.1186/s12920-022-01270-4.
9
A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).
Hum Mutat. 2012 Jan;33(1):8-21. doi: 10.1002/humu.21627. Epub 2011 Nov 3.
10
Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
Breast Cancer. 2019 Jul;26(4):510-519. doi: 10.1007/s12282-019-00951-w. Epub 2019 Feb 6.
引用本文的文献
1
Genetic Spectrum of Lithuanian Familial Hypercholesterolemia Patients.
J Cardiovasc Dev Dis. 2025 May 21;12(5):197. doi: 10.3390/jcdd12050197.
2
Appropriate time interval to update ambiguous genetic diagnosis in inherited arrhythmogenic syndromes.
iScience. 2025 Mar 27;28(5):112300. doi: 10.1016/j.isci.2025.112300. eCollection 2025 May 16.
3
ABE-ultramax for high-efficiency biallelic adenine base editing in zebrafish.
Nat Commun. 2024 Jul 4;15(1):5613. doi: 10.1038/s41467-024-49943-1.
4
Diagnostic yield from cardiac gene testing for inherited cardiac conditions and re-evaluation of pre-ACMG variants of uncertain significance.
Ir J Med Sci. 2024 Aug;193(4):1775-1785. doi: 10.1007/s11845-024-03650-4. Epub 2024 Mar 15.
5
Idiopathic ventricular fibrillation: is it a case for genetic testing?
Herzschrittmacherther Elektrophysiol. 2024 Mar;35(1):19-24. doi: 10.1007/s00399-024-00994-3. Epub 2024 Feb 9.
6
Medical Care Use Among Patients with Monogenic Osteoporosis Due to Rare Variants in LRP5, PLS3, or WNT1.
Calcif Tissue Int. 2023 Aug;113(2):186-194. doi: 10.1007/s00223-023-01101-3. Epub 2023 Jun 6.
本文引用的文献
1
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases.
Heart Rhythm. 2022 Jul;19(7):e1-e60. doi: 10.1016/j.hrthm.2022.03.1225. Epub 2022 Apr 4.
2
Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics.
Eur Heart J. 2022 May 21;43(20):1901-1916. doi: 10.1093/eurheartj/ehab895.
3
Evaluation of Clinical Practices Related to Variants of Uncertain Significance Results in Inherited Cardiac Arrhythmia and Inherited Cardiomyopathy Genes.
Circ Genom Precis Med. 2020 Aug;13(4):e002789. doi: 10.1161/CIRCGEN.119.002789. Epub 2020 Jun 10.
4
Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance.
Circ Genom Precis Med. 2019 May;12(5):e002510. doi: 10.1161/CIRCGEN.119.002510.
5
Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG).
Genet Med. 2019 Jun;21(6):1267-1270. doi: 10.1038/s41436-019-0478-1. Epub 2019 Apr 24.
6
Perceptions of genetic variant reclassification in patients with inherited cardiac disease.
Eur J Hum Genet. 2019 Jul;27(7):1134-1142. doi: 10.1038/s41431-019-0377-6. Epub 2019 Mar 21.
7
Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance.
Neth Heart J. 2019 Jun;27(6):304-309. doi: 10.1007/s12471-019-1250-5.
8
Variants of Uncertain Significance: Should We Revisit How They Are Evaluated and Disclosed?
Circ Genom Precis Med. 2018 Jun;11(6):e002169. doi: 10.1161/CIRCGEN.118.002169.
9
Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy.
Eur J Hum Genet. 2017 Jun;25(7):809-815. doi: 10.1038/ejhg.2017.66. Epub 2017 May 3.
Zotero 插件